About Tokyo Angel Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Clinical Trials at Tokyo Angel Hospital
During the past decade, Tokyo Angel Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.
2020-01-30
2021-10-08
Completed
755
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Tokyo Angel Hospital
According to Clinical.Site data, the most researched conditions in "Tokyo Angel Hospital" are
"Atrial Fibrillation" (1 trials), "Atrial Fibrillation (AF)" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Tokyo Angel Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tokyo Angel Hospital
Most popular intervention types in "Tokyo Angel Hospital" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tokyo Angel Hospital
The vast majority of trials in "Tokyo Angel Hospital" are
2 trials for "All" genders.
Clinical Trials Status at Tokyo Angel Hospital
Currently, there are NaN active trials in "Tokyo Angel Hospital".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Tokyo Angel Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tokyo Angel Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".